1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ISIS 113715: new trials by email Literature Review of ISIS 113715 trials Research Report on ISIS 113715
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715 ISIS 113715 - Type 2 Diabetes Mellitus | Phase 1 | Completed | Ionis Pharmaceuticals, Inc. | 10 | 2006-08-01 | 2007-10-17 |
Diabetes Mellitus, Type 2 (1) · Injection Site Reaction (1)
Ionis Pharmaceuticals, Inc. (1)
United States (1)